Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY
Benzinga Newsdesk 5 months ago
EarningsNews
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(2.26) per share. This is a 352 percent decrease over losses of $(0.50) per share from the same period last year.
Apimeds Pharmaceuticals (AMEX:APUS) reported quarterly losses of $(2.26) per share. This is a 352 percent decrease over losses of $(0.50) per share from the same period last year.